DeLauro Seeks Info From FDA Amid Political Influence Concerns (Nasdaq)
WASHINGTON -(Dow Jones)- Congresswoman Rep. Rosa DeLauro, concerned about political influence in device and drug approvals, wants details about what products the Food and Drug Administration has approved in the last several months.

FDA Issues Complete Response Letter For RISPERDAL(R) CONSTA(R) For The Adjunctive Maintenance Treatment Of Bipolar ... (Medical News Today)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced that the Food and Drug Administration (FDA) has asked for additional information regarding the company's supplemental New Drug Application (sNDA) for RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection.

Abbott Receives FDA Clearance For New CELL-DYN(R) Emerald(TM) Hematology Instrument (Medical News Today)
Abbott (NYSE: ABT) announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald(TM). Abbott's CELL-DYN Emerald will expand the company's hematology platform by offering a high performance, affordable solution for small to mid- sized clinical laboratories.